# EDGAR Filing Document

**Accession Number:** 0001880319
**File Stem:** 0001880319-26-000035
**Filing Date:** 2026-5
**Character Count:** 33538
**Document Hash:** f1ac31ebd6efe9b958bbf32575fab96e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001880319-26-000035.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0001880319-26-000035

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260506

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260506

**DATE AS OF CHANGE**: 20260506

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Perimeter Solutions, Inc.
- **CENTRAL INDEX KEY:** 0001880319
- **STANDARD INDUSTRIAL CLASSIFICATION:** CHEMICALS & ALLIED PRODUCTS [2800]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 332098357
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41027
- **FILM NUMBER:** 26945708

**BUSINESS ADDRESS:**
- **STREET 1:** 8000 MARYLAND AVE., SUITE 350
- **CITY:** CLAYTON
- **STATE:** MO
- **ZIP:** 63105
- **BUSINESS PHONE:** (314) 396-7343

**MAIL ADDRESS:**
- **STREET 1:** 8000 MARYLAND AVE., SUITE 350
- **CITY:** CLAYTON
- **STATE:** MO
- **ZIP:** 63105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Perimeter Solutions, SA
- **DATE OF NAME CHANGE:** 20210826

?xml version='1.0' encoding='ASCII'? prm-20260506

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM 8-K**

**CURRENT REPORT** 

**Pursuant to Section 13 or 15(d)** 

**of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): May 6, 2026**

**PERIMETER SOLUTIONS, INC.**

**(Exact name of registrant as specified in its charter)** 

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41027** | **33-2098357** |
| **(State or other jurisdiction**<br>**of incorporation)** | **(Commission**<br>**File Number)** | **(IRS. Employer**<br>**Identification No.)** |

---

**8000 Maryland Avenue, Suite 350**

**Clayton, Missouri 63105**

**(Address of principal executive offices, including zip code)** 

**(314) 396-7343**

**Registrant's telephone number, including area code** 

**Not Applicable** 

**(Former name or former address, if changed since last report.)** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br>**Symbol(s)** | **Name of each exchange**<br>**on which registered** |
| Common Stock, par value $0.0001 per share | PRM | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 &nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.**

On May 6, 2026, Perimeter Solutions, Inc. (the "Company") issued a press release announcing its financial results for its fiscal quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1.

The information furnished under this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act") or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

**Item 9.01 &nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.**

(d) Exhibits

The following exhibits are being furnished as part of this Current Report on Form 8-K.

---

| | |
|:---|:---|
| **Exhibit**<br>**No.** | **Description** |
| <u>[99.1](prmearningspressreleaseq12.htm)</u> | <u>[Press release issued by Perimeter Solutions, Inc. on](prmearningspressreleaseq12.htm)[May](prmearningspressreleaseq12.htm)[6](prmearningspressreleaseq12.htm)[, 202](prmearningspressreleaseq12.htm)[6](prmearningspressreleaseq12.htm)[.](prmearningspressreleaseq12.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **Perimeter Solutions, Inc.** | **Perimeter Solutions, Inc.** |
| Date: May 6, 2026 | By: | /s/ Kyle Sable |
|  |  | Kyle Sable |
|  |  | Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1** 

**Perimeter Solutions Reports First Quarter 2026 Financial Results** 

May 6, 2026

*First quarter Net Income of $72.9M and Adjusted Net Income of $9.0M*

*Continued value driver execution and recent acquisitions drove first quarter Adjusted EBITDA of $41.2M*

*First quarter Earnings Per Diluted Share of $0.44 and Adjusted Earnings Per Diluted Share of $0.06*

*Entered into key five-year contracts with the United States Defense Logistics Agency for suppressants and with California Department of Forestry for retardants in April 2026*

Clayton, Missouri, May 6, 2026 – Perimeter Solutions, Inc. (NYSE: PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, today reported financial results for its first quarter ended March 31, 2026.

**First Quarter 2026 Results** 

• Net sales increased 74% to $125.1 million in the first quarter, as compared to $72.0 million in the prior year quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fire Safety net sales increased 22% to $45.5 million, as compared to $37.1 million in the prior year quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Specialty Products net sales increased 128% to $79.6 million, as compared to $34.9 million in the prior year quarter.

• Net income during the first quarter was $72.9 million, or $0.44 earnings per diluted share, as compared to net income of $56.7 million, or $0.36 earnings per diluted share in the prior year quarter.

• First quarter non-GAAP adjusted earnings per diluted share was $0.06, as compared to non-GAAP adjusted earnings per diluted share of $0.03 in the prior year quarter.

• Adjusted EBITDA increased 128% to $41.2 million in the first quarter, as compared to $18.1 million in the prior year quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fire Safety Segment Adjusted EBITDA increased 85% to $18.7 million, as compared to $10.1 million in the prior year quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Specialty Products Segment Adjusted EBITDA increased 181% to $22.5 million, as compared to $8.0 million in the prior year quarter.

• Reconciliation tables for non-GAAP measures are available in the attached schedules.

**Capital Allocation** 

• On January 22, 2026, the Company acquired the outstanding capital stock of Medical Manufacturing Technologies, LLC ("MMT") for a total cash purchase price, net of cash acquired of $682.3 million which was funded with cash on hand and proceeds from a senior secured notes offering. MMT is included within the Specialty Products segment.

• The Company invested $5.8 million in capital expenditures during the quarter ended March 31, 2026.

------

**Conference Call and Webcast** 

As previously announced, Perimeter Solutions management will hold a conference call at 8:30 a.m. ET on Wednesday, May 6, 2026 to discuss financial results for the first quarter 2026. The conference call can be accessed by dialing (877) 407-9764 (toll-free) or (201) 689-8551 (toll).

The conference call will also be webcast simultaneously on Perimeter's website (https://ir.perimeter-solutions.com), accessed under the Investor Relations page. The webcast link will be made available on the Company's website prior to the start of the call; go to the investor relations page of our website to the News & Events menu and click on "Events & Presentations."

A slide presentation will also be available for reference during the conference call; go to the investor relations page of our website to the News & Events menu and click on "Events & Presentations."

Following the live webcast, a replay will be available on the Company's website. A telephonic replay will also be available approximately three hours after the call and can be accessed by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and using Access ID "13758345". The telephonic replay will be available until June 6, 2026 (11:59 p.m. ET).

**About Perimeter Solutions**

Perimeter Solutions (NYSE: PRM) is a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications. Perimeter's focus on superior customer service, paired with our Value Driver-focused operating strategy, decentralized operating model, and focus on driving value via capital allocation and capital structure management, fulfills our dual mandate: to serve customers and create value for stockholders. Perimeter is comprised of two segments, Fire Safety, including fire retardants and fire suppressants, and Specialty Products, which currently spans lubricant additives, electronic and electro-mechanical components, and highly engineered machinery for the medical device industry. Perimeter expects to continue expanding its portfolio through organic growth and value creating acquisitions.

**Forward-looking Information** 

This press release may contain "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will," and similar references to future periods.

Any such forward-looking statements are not guarantees of performance or results, and involve risks, uncertainties (some of which are beyond the Company's control) and assumptions. Although Perimeter believes any forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect the Company's actual financial results and cause them to differ materially from those anticipated in any forward-looking statements, including the risk factors described from time to time by us in our filings with the Securities and Exchange Commission ("SEC"), including, but not limited to, the Company's Annual Report on Form 10-K for the year ended December 31, 2025. Stockholders, potential investors and other readers should consider these factors carefully in evaluating the forward-looking statements.

Any forward-looking statement made by Perimeter in this press release speaks only as of the date on which it is made. Perimeter undertakes no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

SOURCE: Perimeter Solutions, Inc.

CONTACT: ir@perimeter-solutions.com

------

**PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES** 

**Condensed Consolidated Statements of Operations and Comprehensive Income**

**(in thousands, except share and per share data)** 

**(Unaudited)** 

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Net sales | $125069 | $72030 |
| Cost of goods sold | 74282 | 43877 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 50787 | 28153 |
| Operating expenses (income): |  |  |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expense | 23061 | 16299 |
| &nbsp;&nbsp;&nbsp;Amortization expense | 22599 | 14099 |
| &nbsp;&nbsp;&nbsp;Founders advisory fees - related party | (76378) | (80613) |
| &nbsp;&nbsp;&nbsp;Other operating expense | 9018 | 561 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating income | (21700) | (49654) |
| Operating income | 72487 | 77807 |
| Other expense (income): |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense, net | 24356 | 9644 |
| &nbsp;&nbsp;&nbsp;Foreign currency gain | (1351) | (1159) |
| &nbsp;&nbsp;&nbsp;Other (income) expense, net | (364) | 143 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense, net | 22641 | 8628 |
| Income before income taxes | 49846 | 69179 |
| Income tax benefit (expense) | 23090 | (12493) |
| Net income | 72936 | 56686 |
| Other comprehensive (loss) income, net of tax: |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | (6566) | 7885 |
| Total comprehensive income | $66370 | $64571 |
| Earnings per share: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $0.47 | $0.38 |
| &nbsp;&nbsp;&nbsp;Diluted | $0.44 | $0.36 |
| Weighted average number of shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 153863650 | 148556284 |
| &nbsp;&nbsp;&nbsp;Diluted | 165074373 | 156727696 |

---

------

**PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES** 

**Condensed Consolidated Balance Sheets** 

**(in thousands, except share data)**

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| **ASSETS** | **(Unaudited)** | |
| Current assets: |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $91624 | $325927 |
| &nbsp;&nbsp;Accounts receivable, net | 87536 | 64363 |
| &nbsp;&nbsp;Inventories | 191026 | 139634 |
| &nbsp;&nbsp;Prepaid expenses and other current assets | 27987 | 34049 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 398173 | 563973 |
| Property, plant and equipment, net | 101296 | 85138 |
| Operating lease right-of-use assets | 37297 | 30152 |
| Finance lease right-of-use assets | 5490 | 5713 |
| Goodwill | 1365415 | 1065211 |
| Customer lists, net | 924377 | 628189 |
| Technology and patents, net | 200318 | 184804 |
| Tradenames, net | 125297 | 86330 |
| Other assets, net | 6715 | 3497 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $3164378 | $2653007 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;Accounts payable | $38408 | $30301 |
| &nbsp;&nbsp;Accrued expenses and other current liabilities | 61322 | 47212 |
| &nbsp;&nbsp;Founders advisory fees payable - related party | 25839 | 95726 |
| &nbsp;&nbsp;Deferred revenue | 3322 | 1879 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 128891 | 175118 |
| Long-term debt, net | 1209650 | 669122 |
| Operating lease liabilities, net of current portion | 32858 | 27860 |
| Finance lease liabilities, net of current portion | 5560 | 5694 |
| Deferred income taxes | 121788 | 80410 |
| Founders advisory fees payable - related party | 338480 | 440697 |
| Preferred stock | 117753 | 115904 |
| Preferred stock - related party | 586 | 1293 |
| Other non-current liabilities | 3963 | 3590 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1959529 | 1519688 |
| Commitments and contingencies |  |  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;Common stock, $0.0001 par value per share, 4,000,000,000 shares authorized; 188,505,219 and 174,818,216 shares issued; 163,127,063 and 149,440,060 shares outstanding at March 31, 2026 and December 31, 2025, respectively | 19 | 17 |
| &nbsp;&nbsp;Treasury stock, at cost; 25,378,156 shares at March 31, 2026 and December 31, 2025 | (168197) | (168197) |
| &nbsp;&nbsp;Additional paid-in capital | 2106116 | 2100958 |
| &nbsp;&nbsp;Accumulated other comprehensive loss | (12936) | (6370) |
| &nbsp;&nbsp;Accumulated deficit | (720153) | (793089) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 1204849 | 1133319 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $3164378 | $2653007 |

---

------

**PERIMETER SOLUTIONS, INC. AND SUBSIDIARIES**

**Condensed Consolidated Statements of Cash Flows** 

**(in thousands)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| **Cash flows from operating activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $72936 | $56686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash (used in) provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Founders advisory fees - related party (change in fair value) | (76378) | (80613) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 27139 | 16893 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest and payment-in-kind on preferred stock | 1904 | 1833 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 2598 | 2671 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash lease expense | 2513 | 1395 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (27055) | 8927 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred financing costs | 709 | 444 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency gain | (1351) | (1159) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal of assets | 17 | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities, net of acquisitions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 3424 | 11830 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (3099) | 2145 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and current other assets | 878 | 766 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (976) | (3513) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 219 | 4564 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable, net | 5338 | 1660 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 2399 | 7253 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Founders advisory fees - related party (cash settled) | (95726) | (6677) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (1903) | (994) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finance lease liabilities | (119) | (127) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | (2428) | (241) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) provided by operating activities | (88961) | 23746 |
| **Cash flows from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase of property and equipment | (5801) | (4813) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase of businesses, net of cash acquired | (682294) | (10000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (688095) | (14813) |
| **Cash flows from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock repurchased |  | (8183) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from exercises of options | 3000 | 41 |
| &nbsp;&nbsp;&nbsp;&nbsp;Principal payments on finance lease obligations | (179) | (251) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of long-term debt | 550000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payment of debt issuance costs | (10057) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | 542764 | (8393) |
| Effect of foreign currency on cash and cash equivalents | (11) | 1054 |
| Net change in cash and cash equivalents | (234303) | 1594 |
| Cash and cash equivalents, beginning of period | 325927 | 198456 |
| Cash and cash equivalents, end of period | $91624 | $200050 |
| **Supplemental disclosures of cash flow information:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest | $154 | $6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash (received) paid for income taxes | $(2034) | $530 |

---

------

**Non-GAAP Financial Metrics** 

The Company provides non-GAAP financial measures for Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted Net Income, and Adjusted Earnings Per Share data as supplemental information regarding the Company's business performance. The Company believes that these non-GAAP financial measures are useful to investors because they provide investors with a better understanding of the Company's past financial performance and future results. The Company's management uses these non-GAAP financial measures when it internally evaluates the performance of its business and makes operating decisions, including internal operating budgeting, performance measurement, and discretionary compensation.

*Adjusted EBITDA and Segment Adjusted EBITDA* 

Adjusted EBITDA and Segment Adjusted EBITDA are defined as income (loss) before income taxes plus net interest and other financing expenses, and depreciation and amortization, adjusted on a consistent basis for certain non-recurring, unusual or non-operational items. These items include (i) restructuring, (ii) acquisition related costs, (iii) founder advisory fee expenses, (iv) stock-based compensation expense, (v) purchase accounting impact and (vi) foreign currency loss (gain). To supplement the Company's condensed consolidated financial statements presented in accordance with U.S. GAAP, Perimeter is providing a summary to show the computations of Adjusted EBITDA and Segment Adjusted EBITDA, which are non-GAAP measures used by the Company's management and by external users of Perimeter's financial statements, such as debt and equity investors, commercial banks and others, to assess the Company's operating performance as compared to that of other companies, without regard to financing methods, capital structure or historical cost basis. Adjusted EBITDA and Segment Adjusted EBITDA should not be considered an alternative to net income (loss), operating income (loss), cash flows provided by (used in) operating activities or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP (in thousands).

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **(Unaudited)** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| | **Fire Safety** | **Specialty<br>Products** | **Total** | **Fire Safety** | **Specialty<br>Products** | **Total** |
| Income (loss) before income taxes | $62127 | $(12281) | $49846 | $58878 | $10301 | $69179 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 14492 | 12647 | 27139 | 12765 | 4128 | 16893 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and financing expense | 10455 | 13901 | 24356 | 5954 | 3690 | 9644 |
| &nbsp;&nbsp;&nbsp;&nbsp;Founders advisory fees - related party | (66890) | (9488) | (76378) | (69327) | (11286) | (80613) |
| &nbsp;&nbsp;&nbsp;Non-recurring expenses <sup>(1)</sup> | 132 | 259 | 391 | 234 | 673 | 907 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition costs | 10 | 8958 | 8968 |  | 561 | 561 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 716 | 1882 | 2598 | 1576 | 1095 | 2671 |
| &nbsp;&nbsp;&nbsp;Purchase accounting impact <sup>(2)</sup> |  | 5590 | 5590 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency (gain) loss | (2351) | 1000 | (1351) | 5 | (1164) | (1159) |
| Segment Adjusted EBITDA | $18691 | $22468 | $41159 | $10085 | $7998 | $18083 |

---

(1) For the three months ended March 31, 2026, $0.3 million was related to litigation costs arising from a contractual dispute regarding control of the P 2 S 5 facility, which is currently operated by Flexsys Chemical Company, and $0.1 million was related to restructuring and other non-recurring costs. For the three months ended March 31, 2025, $0.5 million was related to restructuring and other non-recurring costs, and $0.4 million was related to the Redomiciliation Transaction. <br>

(2) For the three months ended March 31, 2026, $5.6 million was primarily related to the impact of purchase accounting on the cost of inventory sold. The inventory acquired received a purchase accounting step-up in basis.

------

*Adjusted Net Income and Adjusted Earnings Per Share*

The computation of Adjusted Earnings Per Share ("Adjusted EPS") is defined as Adjusted Net Income divided by adjusted diluted shares. Adjusted Net Income is defined as net income (loss) plus amortization, certain non-recurring, unusual or non-operational items, and the tax impact of these non-GAAP adjustments. These adjustments include (i) restructuring, (ii) acquisition related costs, (iii) founder advisory fee expenses, (iv) stock-based compensation expense, (v) purchase accounting impact and (vi) foreign currency loss (gain). Adjusted diluted shares is the weighted average diluted shares outstanding, adjusted by adding dilution for options excluded under U.S. GAAP due to a net loss, less dilution related to founders advisory fees. To supplement the Company's condensed consolidated financial statements presented in accordance with U.S. GAAP, Perimeter is providing a summary to show the computations of Adjusted Net Income and Adjusted EPS, which are non-GAAP measures used by the Company's management and by external users of Perimeter's financial statements, such as debt and equity investors, commercial banks and others, to assess the Company's operating performance as compared to that of other companies, without regard to financing methods, capital structure or historical cost basis. Adjusted EPS and Adjusted Net Income should not be considered alternatives to GAAP earnings (loss) per share ("GAAP EPS"), net income (loss), operating income (loss), cash flows provided by (used in) operating activities or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP (in thousands, except share and per share data).

---

| | | | |
|:---|:---|:---|:---|
| **(Unaudited)** | **(Unaudited)** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
|  |  | **2026** | **2025** |
| GAAP net income | GAAP net income | $72936 | $56686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments: | &nbsp;&nbsp;&nbsp;&nbsp;Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization | 22599 | 14099 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Founders advisory fees - related party | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Founders advisory fees - related party | (76378) | (80613) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-recurring expenses <sup>(1)</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-recurring expenses <sup>(1)</sup> | 391 | 907 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition costs | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition costs | 8968 | 561 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 2598 | 2671 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting impact <sup>(2)</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting impact <sup>(2)</sup> | 5590 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency gain | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency gain | (1351) | (1159) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax impact of non-GAAP adjustments <sup>(3)</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax impact of non-GAAP adjustments <sup>(3)</sup> | (26319) | 10937 |
| Adjusted net income | Adjusted net income | $9034 | $4089 |
| Shares used in computing GAAP Earnings Per Share (diluted) | Shares used in computing GAAP Earnings Per Share (diluted) | 165074373 | 156727696 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options <sup>(4)</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options <sup>(4)</sup> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares underlying Founders fixed advisory fees <sup>(5)</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares underlying Founders fixed advisory fees <sup>(5)</sup> | (4714122) | (7071183) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares underlying Founders variable advisory fees <sup>(6)</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares underlying Founders variable advisory fees <sup>(6)</sup> |  |  |
| Shares used in computing Adjusted Earnings Per Share (diluted) | Shares used in computing Adjusted Earnings Per Share (diluted) | 160360251 | 149656513 |
| GAAP Earnings Per Share (diluted) | GAAP Earnings Per Share (diluted) | $0.44 | $0.36 |
| Adjusted Earnings Per Share (diluted) | Adjusted Earnings Per Share (diluted) | $0.06 | $0.03 |
| ____________________ | ____________________ |  |  |
| (1) | For the three months ended March 31, 2026, $0.3 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company, and $0.1 million was related to restructuring and other non-recurring costs. For the three months ended March 31, 2025, $0.5 million was related to restructuring and other non-recurring costs, and $0.4 million was related to the Redomiciliation Transaction. | For the three months ended March 31, 2026, $0.3 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company, and $0.1 million was related to restructuring and other non-recurring costs. For the three months ended March 31, 2025, $0.5 million was related to restructuring and other non-recurring costs, and $0.4 million was related to the Redomiciliation Transaction. | For the three months ended March 31, 2026, $0.3 million was related to litigation costs arising from a contractual dispute regarding control of the P2S5 facility, which is currently operated by Flexsys Chemical Company, and $0.1 million was related to restructuring and other non-recurring costs. For the three months ended March 31, 2025, $0.5 million was related to restructuring and other non-recurring costs, and $0.4 million was related to the Redomiciliation Transaction. |
| (2) | For the three months ended March 31, 2026, $5.6 million was primarily related to the impact of purchase accounting on the cost of inventory sold. The inventory acquired received a purchase accounting step-up in basis. | For the three months ended March 31, 2026, $5.6 million was primarily related to the impact of purchase accounting on the cost of inventory sold. The inventory acquired received a purchase accounting step-up in basis. | For the three months ended March 31, 2026, $5.6 million was primarily related to the impact of purchase accounting on the cost of inventory sold. The inventory acquired received a purchase accounting step-up in basis. |
| (3) | The tax impact of non-GAAP adjustments reflects the total income tax expense commensurate with the non-GAAP measure of profitability. | The tax impact of non-GAAP adjustments reflects the total income tax expense commensurate with the non-GAAP measure of profitability. | The tax impact of non-GAAP adjustments reflects the total income tax expense commensurate with the non-GAAP measure of profitability. |
| (4) | The Company adds back the dilutive impact of options if amounts were excluded for purposes of GAAP EPS due to a GAAP net loss during the period. | The Company adds back the dilutive impact of options if amounts were excluded for purposes of GAAP EPS due to a GAAP net loss during the period. | The Company adds back the dilutive impact of options if amounts were excluded for purposes of GAAP EPS due to a GAAP net loss during the period. |
| (5) | As of March 31, 2026, a maximum of 2.4 million shares were issuable within 12 months under the Founders fixed advisory fee. | As of March 31, 2026, a maximum of 2.4 million shares were issuable within 12 months under the Founders fixed advisory fee. | As of March 31, 2026, a maximum of 2.4 million shares were issuable within 12 months under the Founders fixed advisory fee. |
| (6) | Based on period end market prices as of March 31, 2026, no shares were issuable within 12 months under the Founders variable advisory fee.  | Based on period end market prices as of March 31, 2026, no shares were issuable within 12 months under the Founders variable advisory fee.  | Based on period end market prices as of March 31, 2026, no shares were issuable within 12 months under the Founders variable advisory fee.  |

---

<br>